Global Active Pharmaceutical Ingredients Market 2017-2021

  • ID: 3987888
  • Report
  • Region: Global
  • 60 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Dr Reddy's Laboratories
  • Ipca Laboratories
  • Lonza Group
  • MORE
About Active Pharmaceutical Ingredients

A drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods.

The analysts forecast the global active pharmaceutical ingredients market to grow at a CAGR of 6.61% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global active pharmaceutical ingredients market for 2017-2021. To calculate the market size, the report considers the sales of APIs in key applications areas of the pharmaceutical industry. The report considers the revenue generated from the sales of cardiovascular drugs, diabetes drugs, central nervous system (CNS) drugs, oncology drugs, and others.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Aurobindo Pharma
- Cipla
- Dr. Reddy's Laboratories
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries
Other prominent vendors
- Abbott Laboratories
- Albemarle
- Amgen
- BASF
- Biocon
- Boehringer Ingelheim
- Bristol-Myers Squibb
- CIRON Drugs & Pharmaceuticals
- Dishman Pharmaceuticals and Chemicals
- Emcure Pharmaceuticals
- Ipca Laboratories
- Johnson Matthey
- Guilin Pharmaceutical
- Johnson & Johnson
- Lonza Group
- Merck
- Novartis
- Pfizer
- Roche
Market drivers
- Strong focus on HPAPI
- For a full, detailed list, view the full report

Market challenges
- Government regulations
- For a full, detailed list, view the full report

Market trends
- Growing influence of key markets
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Dr Reddy's Laboratories
  • Ipca Laboratories
  • Lonza Group
  • MORE
Part 01: Executive summary

Part 02: Scope of the report
  • Market overview
Part 03: Market research methodology
  • Research methodology
  • Economic indicators
Part 04: Introduction
  • Key market highlights
  • Overview
Part 05: Market landscape
  • Global APIs market
  • Five forces analysis
Part 06: Market segmentation by production process
  • Global APIs market by production process
  • Global synthetic APIs market
  • Global biotech APIs market
Part 07: Market segmentation by type
  • Global APIs market by type
Part 08: Market segmentation by vendor type
  • Global APIs market by vendor type
  • Global captive APIs market
  • Global merchant APIs market
Part 09: Geographic segmentation
  • Global APIs market by geography
  • APIs market in Americas
  • APIs market in APAC
  • APIs market in EMEA
  • Global APIs market by therapeutic areas
Part 10: Market drivers
  • Increasing incidence of age-related diseases globally
  • Strong focus on HPAPI
  • Measures against counterfeit drugs
Part 11: Impact of drivers

Part 12: Market challenges
  • Government regulations
  • Fierce competition among API manufacturers
  • Less R&D spending
  • Availability of counterfeit products
Part 13: Impact of drivers and challenges

Part 14: Market trends
  • Growing influence of key markets
  • Emergence of Africa
  • Increasing outsourcing activities
Part 15: Vendor landscape
  • Competitive scenario
  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy’s Laboratories
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries
  • Other prominent vendors
Part 16: Appendix
  • List of abbreviations
Part 17: About the Author

List of Exhibits
Exhibit 01: Global APIs market
Exhibit 02: Market segmentation by production process
Exhibit 03: Market segmentation by type
Exhibit 04: Market segmentation by vendors
Exhibit 05: Market segmentation by geography
Exhibit 06: Global APIs market 2016-2021 ($ billions)
Exhibit 07: Forecast of global APIs market 2016-2021
Exhibit 08: Five forces analysis
Exhibit 09: Global APIs market by production process 2016 and 2021
Exhibit 10: Global synthetic APIs market 2016-2021
Exhibit 11: Forecast for synthetic APIs market 2016-2021
Exhibit 12: Global biotech APIs market 2016-2021 ($ billions)
Exhibit 13: Forecast of biotech APIs market 2016-2021
Exhibit 14: Global biotech APIs market by product type 2016
Exhibit 15: Global APIs market by type 2016 and 2021
Exhibit 16: Global conventional APIs market 2016-2021 ($ billions)
Exhibit 17: Forecast of conventional APIs market 2016-2021
Exhibit 18: Global HPAPIs market 2016-2021 ($ billions)
Exhibit 19: Forecast of HPAPIs market 2016-2021
Exhibit 20: Global HPAPIs market by production process 2016
Exhibit 21: Global HPAPIs market by type 2016
Exhibit 22: Global APIs market by vendor type 2016 and 2021
Exhibit 23: Global captive APIs market 2016-2021 ($ billions)
Exhibit 24: Forecast of captive APIs market 2016-2021
Exhibit 25: Global merchant APIs market 2016-2021 ($ billions)
Exhibit 26: Forecast of merchant APIs market 2016-2021
Exhibit 27: Global merchant APIs market by type 2016
Exhibit 28: Global APIs market by geography 2016 and 2021
Exhibit 29: APIs market in Americas 2016-2021 ($ billions)
Exhibit 30: Forecast of APIs market in Americas 2016-2021
Exhibit 31: Key leading countries in APIs market in Americas 2016
Exhibit 32: APIs market in APAC 2016-2021 ($ billions)
Exhibit 33: Forecast of APIs market in APAC 2016-2021
Exhibit 34: Key leading countries in APIs market in APAC 2016
Exhibit 35: APIs market in EMEA 2016-2021 ($ billions)
Exhibit 36: Forecast of APIs market in EMEA 2016-2021
Exhibit 37: Key leading countries in APIs market in EMEA 2016
Exhibit 38: Global APIs market by therapeutic areas 2016
Exhibit 39: Impact of drivers
Exhibit 40: R&D spending % change 2013-2022
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Key vendors of global APIs market
Exhibit 43: Aurobindo Pharma: Business segmentation
Exhibit 44: Cipla: Business segmentation
Exhibit 45: Dr. Reddy’s Laboratories: Business segmentation by revenue 2015
Exhibit 46: Sun Pharmaceutical Industries Limited: Business segmentation by revenue 2015
Exhibit 47: Teva Pharmaceutical Industries: Business segmentation
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Dr Reddy's Laboratories
  • Ipca Laboratories
  • Lonza Group
  • MORE
New Report Released: – Global Active Pharmaceutical Ingredients Market 2017-2021

The author of the report recognizes the following companies as the key players in the global active pharmaceutical ingredients market: Aurobindo Pharma, Cipla, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries.

Other Prominent Vendors in the market are: Abbott Laboratories, Albemarle, Amgen, BASF, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, CIRON Drugs & Pharmaceuticals, Dishman Pharmaceuticals and Chemicals, Emcure Pharmaceuticals, Ipca Laboratories, Johnson Matthey, Guilin Pharmaceutical, Johnson & Johnson, Lonza Group, Merck, Novartis, Pfizer, Roche.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing influence of key markets. The influence of vendors especially from APAC and to some extent from the Eastern Europe is increasing. India, China, South Korea, and Taiwan are expected to emerge as the leading markets for generics owing to the low production cost. Expertise in process chemistry and low manufacturing and labor costs are the major factors that have contributed to the increased competence of vendors in these countries.”

According to the report, one of the major drivers for this market is strong focus on HPAPI. The demand for HPAPIs is growing considerably during the forecast period due to the increase in the application of targeted therapies for the treatment of diseases. The sustained innovations since 2015 are expected to sustain the market growth in future. The number of drug approvals during 2015 was the highest in recent years. This success is driving the funding for new materials, which is, thereby increasing the R&D of new HPAPIs.

Further, the report states that one of the major factors hindering the growth of this market is government regulations. Vendors are required to comply with the various regulations and must follow extensive procedures. The regulations differ in different regions, and the regulations in the US and Europe are considered the most stringent. The good manufacturing practice (GMP) requirements as stated by the World Health Organization (WHO) provides prequalification of APIs to ensure quality. Vendors that comply with the standards and norms as stated by the WHO are provided with the Active Pharmaceutical Ingredient Master File (APIMF) number and are included in the WHO's prequalified APIs list.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Aurobindo Pharma
  • Cipla
  • Dr Reddy's Laboratories
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries
  • Abbott Laboratories
  • Albemarle
  • Amgen
  • BASF
  • Biocon
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • CIRON Drugs & Pharmaceuticals
  • Dishman Pharmaceuticals and Chemicals
  • Emcure Pharmaceuticals
  • Ipca Laboratories
  • Johnson Matthey
  • Guilin Pharmaceutical
  • Johnson & Johnson
  • Lonza Group
  • Merck
  • Novartis
  • Pfizer
  • Roche
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll